IBN SINA Pharmaceutical Industry Balance Sheet Health
Financial Health criteria checks 5/6
IBN SINA Pharmaceutical Industry has a total shareholder equity of BDT3.6B and total debt of BDT1.6B, which brings its debt-to-equity ratio to 44.3%. Its total assets and total liabilities are BDT6.5B and BDT2.8B respectively. IBN SINA Pharmaceutical Industry's EBIT is BDT836.7M making its interest coverage ratio 14.9. It has cash and short-term investments of BDT310.4M.
Key information
44.3%
Debt to equity ratio
৳1.60b
Debt
| Interest coverage ratio | 14.9x |
| Cash | ৳310.39m |
| Equity | ৳3.62b |
| Total liabilities | ৳2.84b |
| Total assets | ৳6.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IBNSINA's short term assets (BDT2.4B) exceed its short term liabilities (BDT2.1B).
Long Term Liabilities: IBNSINA's short term assets (BDT2.4B) exceed its long term liabilities (BDT744.1M).
Debt to Equity History and Analysis
Debt Level: IBNSINA's net debt to equity ratio (35.7%) is considered satisfactory.
Reducing Debt: IBNSINA's debt to equity ratio has increased from 36.4% to 44.3% over the past 5 years.
Debt Coverage: IBNSINA's debt is well covered by operating cash flow (43.9%).
Interest Coverage: IBNSINA's interest payments on its debt are well covered by EBIT (14.9x coverage).